Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection

Journal of Virological Methods

Volumn 89, Issue 1-2, 2000, Pages 61-73

  Henry, Stanley C ^a   Schmader, Kenneth ^a,c   Brown, Talmage T ^b   Miller, Sara E ^c   Howell, David N ^a,c   Daley, Gerald G ^a   Hamilton, John D ^a,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytomegalovirus infection; Green fluorescent protein; Recombinant cytomegalovirus

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; VIRUS INFECTION;

ACUTE DISEASE; ANIMAL; BIOLOGICAL MARKERS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CELLS, CULTURED; DNA, RECOMBINANT; DNA, VIRAL; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; HERPESVIRIDAE INFECTIONS; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MUROMEGALOVIRUS; PROMOTER REGIONS (GENETICS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0033833211     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(00)00202-0     Document Type: Article

References (40)

1. Balthesen M., Messerle M., Reddehase M.J. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:1993;5360.
2. Britt W.J., Alford C.A. Cytomegalovirus. Fields B.N., Knipe D.M., Howley P.M. Field's virology. third ed :1996;2493-2523 Raven Press, New York.
3. Cardin R.D., Abenes G.B., Stoddart C.A., Mocarski E.S. Murine cytomegalovirus IE2, an activator of gene expression is dispensable for growth and latency in mice. Virolgy. 209:1995;236.
4. Chalfie M., Tu Y., Euskirchen G., Ward W.W., Prasher D.C. Green fluorescent protein as a marker for gene expression. Science. 263:1994;802.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol extraction. Anal. Biochem. 162:1987;156.
6. Collins T., Pomeroy C., Jordan M.C. Detection of latent cytomegalovirus in diverse organs of mice. J. Infect. Dis. 168:1993;725.
7. Cormack B.P., Valdivia R.H., Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 173:1996;33.
8. Ebeling A., Keil G.M., Knust E., Koszinowski U.H. Molecular cloning and physical mapping of murine cytomegalovirus DNA. J. Virol. 47:1983;421.
9. Hahn G., Jores R., Mocarski E.S. Cytomegalovirus remains latent in a common precursor of dendridic and myeloid cells. Proc. Natl. Acad. Sci. USA. 95:1998;3937.
10. Hamilton J.D., Seaworth B.J. Transmission of latent cytomegalovirus in a murine kidney transplantation model. Transplantation. 39:1985;290.
11. Hendrix R.M.G., Wagenaar M., Slobbe R.L., Bruggeman C.A. Widespread presence of cytomegalovirus DNA in tissues of healthy human victims. J. Clin. Pathol. 50:1997;59.
12. Henry S.C., Hamilton J.D. Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice. J. Inf. Dis. 167:1993;950.
13. Ho D.Y., Mocarski E.S. B-galactosidase as a marker in the peripheral and neural tissues of the herpes simples virus-infected mouse. Virology. 167:1988;279.
14. Jordan M.C, Mar V.L. Spontaneous activation of latent cytomegalovirus from murine spleen explants. J. Clin. Invest. 70:1982;762.
15. Keil G.M., Ebeling-Kiel A., Koszinwoski U.H. Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection. J. Virol. 50:1984;784.
16. Klotman M.E., Henry S.C., Greene R.C., Brazy P.C., Klotman P.E., Hamilton J.D. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J. Infect. Dis. 161:1990;220.
17. Koffron A.J., Hummel M., Patterson B.K., Yan S., Kaufman D.B., Fryer J.P., Stuart F.P., Abecassis M.I. Cellular localization of latent murine cytomegalovirus. J. Virol. 72:1998;95.
18. Kondo K., Kaneshima H., Mocarski E.S. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA. 91:1994;11879.
19. Kondo K., Xu J., Mocarski E.S. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA. 93:1996;11137.
20. Kurz S., Steffens H., Mayer A., Harris J.R., Reddehase M.J. Latency versus persistence or intermittant recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:1997;2980.
21. Kurz S., Rapp M., Steffens H.P., Grzimek N.K.A., Schmalz S., Reddehase M.J. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73:1999;482.
22. Maciejewski J.P., Bruening E.E., Donahue R.E., Mocarski E.S., Young N.S., St. Jeor S.C. Infection of hematopoetic progenitor cells by human cytomegalovirus. Blood. 80:1992;170.
23. Manning W.C., Mocarski E.S. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology. 167:1988;477.
24. Manning W.C., Stoddart C.A., Lagenaur L.A., Abenes G.B., Mocarski E.S. Cytomegalovirus determinant of replication in salivary glands. J. Virol. 66:1992;3794.
25. Mercer J.A., Wiley C.A., Spector D.H. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62:1988;987.
26. Mims C.A., Gould J. Splenic necrosis in mice infected with cytomegalovirus. J. Inf. Dis. 137:1978;587.
27. Mims C.A., Gould J. Infection of salivary glands, kidneys, adrenals, ovaries, and epithelia by murine cytomegalovirus. J. Med. Microbiol. 12:1979;113.
28. Minton E.J., Tysoe C., Sinclair J.H., Sissons J.G. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:1994;4017.
29. Mitchell B.M., Leung A., Stevens J.G. Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes. Virology. 223:1996;198.
30. Pomeroy C., Hillern P.J., Jordan M.C. Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J. Virol. 65:1991;3330.
31. Pollock J.L., Virgin H.W. Latency without persistence of murine cytomegalovirus in spleen and kidney. J. Virol. 69:1994;1762.
32. Pollock J.L., Presti R.M., Paetzold S., Virgin H.W. Latent murine cytomegalovirus infection in macrophages. Virology. 227:1997;168.
33. Sonderberg-Naucler C., Fish K.N., Nelson J.A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 91:1997;119.
34. Spaete R.R., Mocarski E.S. Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc. Natl. Acad. Sci. USA. 84:1987;7213.
35. Stoddart C.A., Cardin R.D., Boname J.M., Manning W.C., Abenes G.B., Mocarski E.S. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:1994;6243.
36. Taylor-Wiedeman J., Sissons P., Borysiewicz L.K., Sinclair J.H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:1991;2059.
37. Taylor-Wiedeman J., Sissons P., Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1994;1597.
38. Van den Pol A.N., Mocarski E., Saederup N., Vieira J., Meier T.J. Cytomegalovirus cell tropism, replication and gene transfer in brain. J. Neurosci. 19:1999;10948.
39. Yu Y., Henry S.C., Xu F., Hamilton J.D. Expression of a murine cytomegalovirus early-late gene in "latently" infected mice. J. Inf. Dis. 172:1995;371.
40. Yuhasz S.A., Dissette V.B., Cook M.L., Stevens J.G. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology. 202:1994;272.